Home / Inspections / 1063021

FDA Inspection 1063021 — Oklahoma Blood Institute Southern

Oklahoma Blood Institute Southern — FEI 1629859

The FDA completed an inspection of Oklahoma Blood Institute Southern on August 7, 2018 in Ardmore, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 7, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ardmore, OK (United States)

Facility

Other inspections at this facility

  • 1318386 (NAI Tue May 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1113305 (NAI Fri Dec 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 971948 (NAI Fri Mar 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 882490 (NAI Fri Jun 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 777898 (NAI Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources